OR WAIT null SECS
January 12, 2012
The pharmaceutical majors advance vaccines for the developing world.
December 29, 2011
Pfizer and GlaxoSmithKline have announced separate agreements with the GAVI Alliance to supply pneumococcal vaccines to developing countries. Pneumococcal disease can lead to pneumonia, meningitis, and sepsis, and is one of leading causes of death in children under the age of five in developing countries.
December 23, 2011
Pfizer and GlaxoSmithKline have announced separate agreements with the GAVI Alliance to supply pneumococcal vaccines to developing countries.
December 22, 2011
Last week, the US Department of Health and Human Services and Novartis Vaccines and Diagnostics dedicated a manufacturing plant that can create influenza vaccine using cultured animal cells instead of the conventional expression system of fertilized eggs.
October 06, 2011
EMA released two concept papers for consultation that address the need to revise existing guidelines on biosimilar medicines and influenza vaccines.
October 02, 2011
Manufacturers fund research and reduce prices to tackle diseases.
July 21, 2011
FDA Approves the Influenza Vaccine Formulation for the 2011-2012 Flu Season.
March 25, 2011
Novartis has completed the acquisition of a majority stake in Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. — one of the largest privately held vaccines companies in China.
March 24, 2011
Novartis acquired a majority stake in Zhejiang Tianyuan Bio-Pharmaceutical, one of the largest privately held vaccine companies in China. The acquisition gives Novartis an expanded presence in the Chinese vaccine market and will facilitate the introduction of Novartis's vaccines into the country.
March 10, 2011
Japan has suspended the use of two pediatric vaccines made by Pfizer and sanofi following the deaths of four children in three days.